Sinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru

By Sam | August 20, 2020

Sinopharm has announced that it will launch another phase 3 trial of its experimental COVID-19 vaccine candidate, this time in Peru, following a greenlight from the Peruvian health regulator.
Source: Devices & Diagnostics Letter